top of page
Grey Round Patterns
Sherringford's logo

Breakthrough Stem Cell Therapy for Spina Bifida Reverses Brain Damage in the Womb

  • Feb 27
  • 2 min read
This detailed medical illustration shows a developing human fetus inside the womb, surrounded by amniotic fluid and featuring a reddish glow on the spinal area under a warm, soft ambient light.

In what experts are calling a "major milestone" in the treatment of birth defects, a pioneering clinical trial has successfully utilized stem cells during in-utero surgery to treat unborn babies with spina bifida.


The Phase I trial, recently published in The Lancet, focused on fetuses diagnosed with myelomeningocele, the most severe form of spina bifida. In this condition, the baby's spinal cord fails to develop properly, leaving delicate tissue exposed and leading to lifelong challenges such as paralysis and loss of bladder control. While standard surgery in the womb can close the gap, it often falls short of preventing all long-term neurological issues.


Led by Dr. Diana Farmer at the University of California, Davis, the surgical team enhanced the standard procedure for six pregnant women whose fetuses were at 24 to 25 weeks of gestation. Before sewing up the skin, the surgeons applied a specialized patch containing placenta-derived mesenchymal stem cells directly onto the exposed spinal cords. These specific stem cells are celebrated for their ability to reduce inflammation, promote healing, and protect nerve tissues.


The early results have been remarkably promising. All six infants were born with intact spinal repairs and showed no signs of abnormal tissue growth or tumors—a primary safety concern when working with stem cells. Most significantly, post-birth MRI scans confirmed that a severe brain complication associated with spina bifida, known as hindbrain herniation, was completely reversed in every case.

Real-world impacts are already visible. The mother of a four-year-old boy from the trial reported that her son is now walking, running, and jumping, and has completely bypassed the need for a wheelchair or interventions for bladder control.


Researchers are now organizing a larger trial involving 35 fetuses to further assess the treatment's safety and efficacy. If these long-term studies confirm the early benefits, this innovative stem cell patch could soon become the standard of care, offering profound new hope for families worldwide.



🔖 Sources






Keywords: Stem Cell Therapy for Spina Bifida

Stem Cell Therapy for Spina Bifida



Sherringford logo

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating

To keep our content free, we rely on ads.

We're 🧠dedicated to making them as non-disruptive as 👍possible.

We really appreciate your 🫀support🫀 in helping us keep the lights on!

Subscribe to Sherringford's weekly newsletter

We designed Sherringford.org to be more than just an educational resource; it's a platform intended to bring a refreshing twist to your daily professional life.

bottom of page